Omada Health, Inc. OMDA
$20.67
$0.844.21%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 87.84M | 78.05M | 75.85M | 68.03M | 61.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 87.84M | 78.05M | 75.85M | 68.03M | 61.37M |
| Cost of Revenue | 24.05M | 29.36M | 22.18M | 22.96M | 21.07M |
| Gross Profit | 63.79M | 48.69M | 53.66M | 45.07M | 40.31M |
| SG&A Expenses | 45.61M | 40.78M | 38.83M | 37.28M | 34.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 84.29M | 82.83M | 72.57M | 70.54M | 65.72M |
| Operating Income | 3.55M | -4.78M | 3.28M | -2.51M | -4.34M |
| Income Before Tax | 5.29M | -2.97M | 5.16M | -3.18M | -5.31M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.29M | -2.97M | 5.16M | -3.18M | -5.31M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.29M | -2.97M | 5.16M | -3.18M | -5.31M |
| EBIT | 3.55M | -4.78M | 3.28M | -2.51M | -4.34M |
| EBITDA | 5.13M | -3.27M | 4.73M | -1.15M | -2.99M |
| EPS Basic | 0.09 | -0.05 | 0.09 | -0.06 | -0.24 |
| Normalized Basic EPS | 0.06 | -0.03 | 0.06 | -0.01 | -0.15 |
| EPS Diluted | 0.08 | -0.05 | 0.08 | -0.06 | -0.24 |
| Normalized Diluted EPS | 0.05 | -0.03 | 0.05 | -0.01 | -0.15 |
| Average Basic Shares Outstanding | 59.69M | 58.92M | 58.06M | 57.66M | 21.97M |
| Average Diluted Shares Outstanding | 63.95M | 58.92M | 63.93M | 57.66M | 21.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |